Y Biologics
Company Details
Status: Private
Employees: 1-10
Location:
Daejeon 34013
Type:
sample
Technology:
sample
sample
sample
About: Y-Biologics is Korea’s leading R&D biotech company in the field of antibody drug development.
Since establishing Y-Biologics in 2007, our company has focused on the research and development of antibody therapeutics, successfully building two main platform technologies: Ymax®-ABL, a unique human antibody library, and ALiCE, a novel format for bispecific T-cell engager antibodies. Utilizing our excellent and differentiated platform technologies, we are striving to become a leading global antibody drug development company in the field of immuno-oncology.
Here at Y-Biologics, with our full-cycle antibody development capabilities, we are pursuing full-fledged development of immuno-oncologic drugs using our bispecific antibody platform. We aim to address unmet medical needs by developing a next-generation immunotherapeutics with higher patient response rates and superior efficacy in comparison to existing immuno-oncology drugs.
Y-SERVICE Technologys_Antibody Screening, Protein Expression, Cell Line Development, Analysis Service
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Y Biologics | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.